Log In
BCIQ
Print this Print this
 

liquid ursodeoxycholic acid

  Manage Alerts
Collapse Summary General Information
Company Retrophin Inc.
DescriptionLiquid formulation of ursodeoxycholic acid (UDCA), a naturally occuring bile acid
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentRegistration
Standard IndicationCirrhosis
Indication DetailsTreat primary biliary cholangitis (PBC)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$59.0M

$0.5M

$58.5M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/20/2016

$59.0M

$0.5M

$58.5M

Get a free BioCentury trial today